Jawed I, Wilkerson J, Prasad V, Duffy AG, Fojo T. Colorectal cancer survival gains and novel treatment regimens: a systematic review and analysis. JAMA Oncol. 2015;1:787–95.

Article  PubMed  Google Scholar 

Kuderer NM, Desai A, Lustberg MB, Lyman GH. Mitigating acute chemotherapy-associated adverse events in patients with cancer. Nat Rev Clin Oncol. 2022;19:681–97.

Article  PubMed  Google Scholar 

Pathak R, Giri S, Aryal MR, Karmacharya P, Bhatt VR, Martin MG. Mortality, length of stay, and health care costs of febrile neutropenia-related hospitalizations among patients with breast cancer in the United States. Support Care Cancer. 2015;23:615–7.

Article  PubMed  Google Scholar 

Bhattacharya V, Barooah PS, Nag TC, Chaudhuri GR, Bhattacharya S. Detail microscopic analysis of deep fascia of lower limb and its surgical implication. Indian J Plast Surg Off Publ Assoc Plast Surg India. 2010;43:135–40.

Article  Google Scholar 

Paessens BJ, von Schilling C, Berger K, Shlaen M, Müller-Thomas C, Bernard R, et al. Health resource consumption and costs attributable to chemotherapy-induced toxicity in German routine hospital care in lymphoproliferative disorder and NSCLC patients. Ann Oncol. 2011;22:2310–9.

Article  CAS  PubMed  Google Scholar 

McKenzie H, Hayes L, White K, Cox K, Fethney J, Boughton M, et al. Chemotherapy outpatients’ unplanned presentations to hospital: a retrospective study. Supp Care Cancer. 2011;19:963–9.

Article  Google Scholar 

National Cancer Institute. Common Terminology Criteria for adverse events (CTCAE V5.0). National Institute of Health 2017. http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_5.0

Di Maio M, Basch E, Denis F, Fallowfield LJ, Ganz PA, Howell D, et al. The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline. Ann Oncol. 2022;33:878–92.

Article  PubMed  Google Scholar 

Catt S, Starkings R, Shilling V, Fallowfield L. Patient-reported outcome measures of the impact of cancer on patients’ everyday lives: a systematic review. J Cancer Surviv. 2017;11:211–32.

Article  PubMed  Google Scholar 

Pérez-Alfonso KE, Sánchez-Martínez V. Electronic Patient-Reported Outcome Measures Evaluating Cancer Symptoms: A Systematic Review. Semin Oncol Nurs. 2021;37:151145.

Basch E, Reeve BB, Mitchell SA, Clauser SB, Minasian LM, Dueck AC, et al. Development of the national cancer institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst. 2014;106:1–11.

Article  Google Scholar 

Aiyegbusi OL, Nair D, Peipert JD, Schick-Makaroff K, Mucsi I. A narrative review of current evidence supporting the implementation of electronic patient-reported outcome measures in the management of chronic diseases. Ther Adv Chronic Dis. 2021;12:20406223211015958.

Charbonneau DH, Hightower S, Katz A, Zhang K, Abrams J, Senft N, et al. Smartphone apps for cancer: A content analysis of the digital health marketplace. Digit Heal. 2020;6:1–7.

Google Scholar 

Osborn J, Ajakaiye A, Cooksley T, Subbe CP. Do mHealth applications improve clinical outcomes of patients with cancer? A critical appraisal of the peer-reviewed literature. Support Care Cancer. 2020;28:1469–79.

Article  PubMed  Google Scholar 

Consolo L, Castellini G, Cilluffo S, Basile I, Lusignani M. Electronic patient-reported outcomes (e-PROMs) in palliative cancer care: a scoping review. J Patient-Reported Outcomes. 2022;6:102.

van den Hurk CJG, Mols F, Eicher M, Chan RJ, Becker A, Geleijnse G, et al. A narrative review on the collection and use of electronic patient-reported outcomes in cancer survivorship care with emphasis on symptom monitoring. Curr Oncol. 2022;29:4370–85.

Article  PubMed  PubMed Central  Google Scholar 

Kofoed S, Breen S, Gough K, Aranda S. Benefits of remote real-time side-effect monitoring systems for patients receiving cancer treatment. Oncol Rev. 2012;6:51–63.

Article  Google Scholar 

Bouganim N, Dranitsaris G, Hopkins S, Vandermeer L, Godbout L, Dent S, et al. Prospective validation of risk prediction indexes for acute and delayed chemotherapy-induced nausea and vomiting. Curr Oncol. 2012;19:414–21.

Article  Google Scholar 

Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: A randomized controlled trial. J Clin Oncol. 2016;34:557–65.

Article  CAS  PubMed  Google Scholar 

Basch E, Schrag D, Henson S, Jansen J, Ginos B, Stover AM, et al. Effect of electronic symptom monitoring on patient-reported outcomes among patients with metastatic cancer: a randomized clinical trial. JAMA. 2022;327:2413–22.

Article  PubMed  PubMed Central  Google Scholar 

Berry DL, Hong F, Halpenny B, Partridge AH, Fann JR, Wolpin S, et al. Electronic self-report assessment for cancer and self-care support: Results of a multicenter randomized trial. J Clin Oncol. 2014;32:199–205.

Article  PubMed  Google Scholar 

Knoerl R, Hong F, Blonquist T, Berry D. Impact of electronic self-assessment and self-care technology on adherence to clinician recommendations and self-management activity for cancer treatment-related symptoms: Secondary analysis of a randomized controlled trial. JMIR Cancer. 2019;5:e11395.

Maguire R, Fox PA, McCann L, Miaskowski C, Kotronoulas G, Miller M, et al. The eSMART study protocol: A randomised controlled trial to evaluate electronic symptom management using the advanced symptom management system (ASyMS) remote technology for patients with cancer. BMJ Open. 2017;7:7–9.

Article  Google Scholar 

Strasser F, Blum D, Von Moos R, Cathomas R, Ribi K, Aebi S, et al. The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MOSAIC, a multicenter cluster-randomized phase III study (SAKK 95/06). Ann Oncol. 2016;27:324–32.

Article  CAS  PubMed  Google Scholar 

Absolom K, Warrington L, Hudson E, Hewison J, Morris C, Holch P, et al. Phase III randomized controlled trial of eRAPID: EHealth intervention during chemotherapy. J Clin Oncol. 2021;39:734–47.

Article  CAS  PubMed  Google Scholar 

Denis F, Lethrosne C, Pourel N, Molinier O, Pointreau Y, Domont J, et al. Randomized trial comparing a web-mediated follow-up with routine surveillance in lung cancer patients. J Natl Cancer Inst. 2017;109:1–8.

Article  Google Scholar 

Denis F, Basch E, Septans A, Bennouna J, Urban T, Dueck A, et al. Two-Year Survival Comparing Web-Based Symptom Monitoring vs Routine Surveillance Following Treatment for Lung Cancer. JAMA. 2019;321:306–7.

Mir O, Ferrua M, Fourcade A, Mathivon D, Duflot-Boukobza A, Dumont S, et al. Digital remote monitoring plus usual care versus usual care in patients treated with oral anticancer agents: the randomized phase 3 CAPRI trial. Nat Med. 2022;28:1224–31.

Article  CAS  PubMed  Google Scholar 

Denis F, Viger L, Charron A, Voog E, Dupuis O, Pointreau Y, et al. Detection of lung cancer relapse using self-reported symptoms transmitted via an Internet Web-application: Pilot study of the sentinel follow-up. Support Care Cancer. 2014;22:1467–73.

Article  PubMed  Google Scholar 

Helissey C, Duverger C, Vanquaethem H, Meghiref Y, Parnot C. Improving cancer patient care with a digital telemonitoring platform: The ConnectPatienToDoctor study. J Clin Oncol. 2021;39:1581.

Article  Google Scholar 

Mendoza TR, Dueck AC, Bennett AV, Mitchell SA, Reeve BB, Atkinson TM, et al. Evaluation of different recall periods for the US National Cancer Institute’s PRO-CTCAE. Clin Trials. 2017;14:255–63.

Article  PubMed  PubMed Central  Google Scholar 

Mokkink LB, Prinsen CAC, Bouter LM, de Vet HCW, Terwee CB. The COnsensus-based standards for the selection of health measurement INstruments (COSMIN) and how to select an outcome measurement instrument. Brazilian J Phys Ther. 2016;20:105–13.

Article  Google Scholar 

NCI-PRO-CTCAETM Items -French for France, Belgium, Switzerland. https://healthcaredelivery.cancer.gov/pro-ctcae/instruments/pro-ctcae/pro-ctcae_french_(belgium_france_switzerland).pdf. Accessed Jan 20 2021.

Patel-Syed Z, Becker S, Olson M, Rinella H, Scott K. What do you think it means? Using cognitive interviewing to improve measurement in implementation science: description and case example. Implement Sci Commun. 2024;5:14.

Egger-Rainer A. Enhancing validity through cognitive interviewing. A methodological example using the Epilepsy Monitoring Unit Comfort Questionnaire. J Adv Nurs. 2019;75:224–33.

Hennink M, Kaiser BN. Sample sizes for saturation in qualitative research: A systematic review of empirical tests. Soc Sci Med. 2022;292:114523.

Article  PubMed  Google Scholar 

Botsch RE. Significance and Measures of Association, 2009–2011. [Last updated on 2011 Aug 11]. Available from: http://www.usca.edu/polisci/apls301/Text/Chapter12.SignificanceandMeasuresofAssociation.htm.

Panattoni L, Fedorenko C, Greenwood-Hickman MA, Kreizenbeck K, Walker JR, Martins R, et al. Characterizing potentially preventable cancer- and chronic disease-related emergency department use in the year after treatment initiation: a regional study. J Oncol Pract. 2018;14:e176–85.

Article  PubMed  Google Scholar 

Mayer DK, Travers D, Wyss A, Leak A, Waller A. Why do patients with cancer visit emergency departments? Results of a 2008 population study in North Carolina. J Clin Oncol Off J Am Soc Clin Oncol. 2011;29:2683–8.

Article  Google Scholar 

Kotronoulas G, Kearney N, Maguire R, Harrow A, Di Domenico D, Croy S, et al. What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. J Clin Oncol Off J Am Soc Clin Oncol. 2014;32:1480–501.

Article  Google Scholar 

Velikova G, Booth L, Smith AB, Brown PM, Lynch P, Brown JM, et al. Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial. J Clin Oncol. 2004;22:714–24.

Article  PubMed  Google Scholar 

Basch E, Deal AM, Dueck AC, Scher HI, Kris MG, Hudis C, et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA. 2017;318:197–8.

Article  PubMed  PubMed Central  Google Scholar 

Luna-Pérez P, Rodríguez DF, Luján L, Alvarado I, Kelly J, Rojas ME, et al.